FSCN1 and neoplasm: Notably, beyond inducing tumor catalytic therapy via targeted ROS generation, CuPaeNs directly disrupted the actin-bundling activity of fascin, as evidenced by molecular docking, isothermal titration calorimetry, co-immunoprecipitation, and immunofluorescence assays.